Have you noticed that Kirk Adams’ formula for getting into office isn’t by running on his record? It’s by BLATANTLY lying about his opponent.
Not only does Adams continue lying that Matt Salmon lobbied for ObamaCare (he didn’t), but he also has his campaign volunteers lying on his behalf as well!
Here is some well documented evidence that Mat Salmon did NOT lobby for ObamaCare:
GilbertWatch Responds to a Kik Adams Supporter
Was Matt Salmon a lobbyist? Yes. Did he lobby for ObamaCare? No. In fact, none of his business partners ever lobbied for ObamaCare. Did his business partner, John Haddow, lobby on behalf of his client, Lundbeck, to remove an onerous provision in the Affordable Health Choices Act? Yes. That small-company-killing provision was buried in the behemoth that is called ObamaCare.
There are thousands of provisions in that monstrosity, and they are negatively affecting many, many businesses. In fact, they are probably affecting YOUR business right now. (Did you get your rebate check from your private "free enterprise" health insurance carrier, as our own federal government ordered them to do? Via ObamaCare, you are to distribute that money back to your employees following an extremely "easy to understand" federal formula.)
Kirk Adams keeps lying, so here’s the latest piece of evidence to prove he’s lying: An email from the head of Lundbeck Pharmaceutical company, Mike Eging, asserting that NO, Matt Salmon didn’t represent them. And please note, the lobbying had literally nothing to do with supporting ObamaCare:
(Sometimes I feel like Dr. Doolittle talking to the animals.)
From: Mile Eging <mleging@msn.com>
Date: Saturday, August 18, 2012 5:00 PM
To: John M Haddow <jhaddow@upstreamdc.com>
Subject: Consulting Work
I was the head of the Washington office from 2009-2012 for Lundbeck Pharmaceutical company, which retained Policy Impact Communications and later Upstream Consulting in Washington, DC. John Haddow was our consultant from this firm. His background in health care while serving as a staff member of the key health committee was the driving force in our retaining him. Our first goal was to allow the health reform bill to fail but absent that we had to make a critical change. John was tasked to assist in changing the onerous language pertaining to Section 340B, particularly as it applied to Orphan products. Our team was successful in reversing the changes negotiated by the hospitals and the Obama administration.
Matt Salmon did not work on our account.
Michael Eging